Identifying Genetic Markers That Predict Response to Paclitaxel in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Stopped Terminated due to slow accrual.
Conditions
- Ovarian Cancer
- Peritoneal Cavity Cancer
Interventions
- GENETIC: Microarray analysis
- OTHER: Laboratory biomarker analysis
Sponsor
M.D. Anderson Cancer Center
Collaborators